awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34660907-AA7C1800-A6D9-455D-9E54-548294257D75
Q34660907-AA7C1800-A6D9-455D-9E54-548294257D75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660907-AA7C1800-A6D9-455D-9E54-548294257D75
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic color
P921
Q34660907-AA7C1800-A6D9-455D-9E54-548294257D75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660907-AA7C1800-A6D9-455D-9E54-548294257D75
rank
NormalRank
type
BestRank
Statement
P921
multicenter trial